Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:(%22CALCEDOIN%2A%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5633

  • Page / 226
Export

Selection :

  • and

The Multifaceted Poliovirus 2A Protease: Regulation of Gene Expression by Picornavirus ProteasesCASTELLO, Alfredo; ALVAREZ, Enrique; CARRASCO, Luis et al.Journal of Biomedicine and Biotechnology (Print). 2011, Vol 2011, issn 1110-7243, 369648.1-369648.23, 1Article

Peginterferon Alfa-2a: A review of approved and investigational usesMATTHEWS, S. James; MCCOY, Christopher.Clinical therapeutics. 2004, Vol 26, Num 7, pp 991-1025, issn 0149-2918, 35 p.Article

Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersBARRIL, G; QUIROGA, J. A; SANZ, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 37-44, issn 0269-2813, 8 p.Article

Randomized dose-escalation study evaluating peginterferon Alfa-2a in patients with metastatic malignant melanomaDUMMER, Reinhard; GARBE, Claus; THOMPSON, John A et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1188-1194, issn 0732-183X, 7 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis BRIJCKBORST, Vincent; TER BORG, Martijn J; VERHEY, Elke et al.The American journal of gastroenterology. 2010, Vol 105, Num 8, pp 1762-1769, issn 0002-9270, 8 p.Article

Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3SHIFFMAN, Mitchell L; SUTER, Fredy; ZEUZEM, Stefan et al.The New England journal of medicine. 2007, Vol 357, Num 2, pp 124-134, issn 0028-4793, 11 p.Article

INTRAMOLECULAR C-ALKYLATION IN BETA GAMMA -UNSATURATED DIAZOKETONES: A NEW SYNTHETIC ROUTE TO ANGULARLY FUSED CYCLOBUTANONES AND GAMMA -LACTONESGHATAK UR; BALJAYANTI SANYAL MAITRA.1974; J. CHEM. SOC., CHEM. COMMUNIC.; G.B.; DA. 1974; NO 21; PP. 876-877; BIBL. 11 REF.Article

Hepatitis B Virus Surface Antigen Levels : A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis BROSSANA BRUNETTE, Maurizia; MORICONI, Francesco; WOLF, Eva et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1141-1150, issn 0270-9139, 10 p.Article

The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infectionDOMAGALSKI, K; PAWLOWSKA, M; ZALESNA, A et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 11, pp 2025-2033, issn 0934-9723, 9 p.Article

Host Gene Expression Changes Correlating With Anti-HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2aHUBBARD, Jonathan J; GREENWELL-WILD, Teresa; BARRETT, Lisa et al.The Journal of infectious diseases. 2012, Vol 205, Num 9, pp 1443-1447, issn 0022-1899, 5 p.Article

Identifying Hepatitis C Virus Genotype 2/3 Patients Who Can Receive a 16-Week Abbreviated Course of Peginterferon Alfa-2a (40KD) Plus RibavirinDIAGO, Moises; SHIFFMAN, Mitchell L; BRONOWICKI, Jean-Pierre et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 6, pp 1897-1903, issn 0270-9139, 7 p.Article

Peginterferon α-2a Plus Ribavirin in Latino and Non-Latino Whites With HCV Genotype 1: Histologic Outcomes and Tolerability From the LATI NO StudyBALART, Luis A; LISKER-MELMAN, Mauricio; HAMZEH, Fayez M et al.The American journal of gastroenterology. 2010, Vol 105, Num 10, pp 2177-2185, issn 0002-9270, 9 p.Article

Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients : Randomized Comparison of Direct Observed Therapy and Self-AdministrationBONKOVSKY, Herbert L; TICE, Alan D; YAPP, Rockford G et al.The American journal of gastroenterology. 2008, Vol 103, Num 11, pp 2757-2765, issn 0002-9270, 9 p.Article

Peginterferon Alfa-2a for AIDS-Associated Kaposi Sarcoma: Experience With 10 PatientsROKX, Casper; VAN DER ENDE, Marchina E; VERBON, Annelies et al.Clinical infectious diseases. 2013, Vol 57, Num 10, pp 1497-1499, issn 1058-4838, 3 p.Article

ETUDE RMP DES PRODUITS DE CONDENSATION PHOTOCHIMIQUE DES BUTYL-9 ET DIBUTYL-9,10 PHENANTHRENES AVEC L'ANHYDRIDE MALEIQUETSITSISHVILI VG; LEKVEISHVILI EH G.1974; SOOBSHCH. AKAD. NAUK GRUZ. S.S.R.; S.S.S.R.; DA. 1974; VOL. 73; NO 1; PP. 73-76; ABS. GEORGIEN ANGL.; BIBL. 5 REF.Article

Safety and Efficacy of Locally Manufactured Pegylated Interferon in Hepatitis C PatientsJABBARI, Hossain; BAYATIAN, Ayatollah; AMIR HOUSHANG SHARIFI et al.Archives of Iranian medicine. 2010, Vol 13, Num 4, pp 306-312, 7 p.Article

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirinSNOECK, Eric; WADE, Janet R; DUFF, Frank et al.British journal of clinical pharmacology. 2006, Vol 62, Num 6, pp 699-709, issn 0306-5251, 11 p.Article

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirinFERENCI, Peter; FRIED, Michael W; CRAXI, Antonio et al.Journal of hepatology. 2005, Vol 43, Num 3, pp 425-433, issn 0168-8278, 9 p.Article

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPRATI, Daniele; SHIFFMAN, Mitchell L; ZEUZEM, Stefan et al.Journal of hepatology. 2006, Vol 44, Num 4, pp 679-685, issn 0168-8278, 7 p.Article

Early Serum HBsAg Drop : A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative PatientsMOUCARI, Rami; MACKIEWICZ, Vincent; VALLA, Dominique et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1151-1157, issn 0270-9139, 7 p.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsGOWIN, Krisstina; THAPALIYA, Prakash; CAMORIANO, John et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1570-1573, issn 0390-6078, 4 p.Article

Temporal associations between interleukin 22 and the extracellular domains of IL-22R and Il-10R2JING LI; TOMKINSON, Kathy N; DE ZUTTER, Gerard et al.International immunopharmacology. 2004, Vol 4, Num 5, pp 693-708, issn 1567-5769, 16 p.Article

Tell El-Yahudiyah Juglets from a Potter's Refuse Pit at AfulaZEVULUN, U.Eretz-Israel. 1990, Vol 21, pp 174-190Article

  • Page / 226